BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21252503)

  • 1. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study.
    Alvestrand A; Ledebo I; Hagerman I; Wingren K; Mattsson E; Qureshi AR; Gutierrez A
    Blood Purif; 2011; 32(1):21-9. PubMed ID: 21252503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.
    Chan CT; Floras JS; Miller JA; Richardson RM; Pierratos A
    Kidney Int; 2002 Jun; 61(6):2235-9. PubMed ID: 12028465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients.
    Weinreich T; De los Ríos T; Gauly A; Passlick-Deetjen J
    Clin Nephrol; 2006 Dec; 66(6):433-9. PubMed ID: 17176915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disadvantage of long-term CAPD for preserving cardiac performance: an echocardiographic study.
    Takeda K; Nakamoto M; Hirakata H; Baba M; Kubo M; Fujishima M
    Am J Kidney Dis; 1998 Sep; 32(3):482-7. PubMed ID: 9740166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.
    Cannella G; Paoletti E; Ravera G; Cassottana P; Araghi P; Mulas D; Peloso G; Delfino R; Messa P
    Kidney Int; 2000 Jul; 58(1):260-8. PubMed ID: 10886571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction.
    Ganda A; Weiner SD; Chudasama NL; Valeri AM; Jadoon A; Shimbo D; Radhakrishnan J
    Clin Nephrol; 2012 May; 77(5):366-75. PubMed ID: 22551882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
    Savage T; Giles M; Tomson CV; Raine AE
    Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.
    Kutlay S; Dincer I; Sengül S; Nergizoglu G; Duman N; Ertürk S
    Am J Kidney Dis; 2006 Mar; 47(3):485-92. PubMed ID: 16490628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.
    Yilmaz R; Altun B; Kahraman S; Ozer N; Akinci D; Turgan C
    Ren Fail; 2010; 32(8):903-12. PubMed ID: 20722555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
    Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Giacone G; Stancanelli B; Cataliotti A; Malatino LS
    Kidney Int; 2004 Apr; 65(4):1492-8. PubMed ID: 15086493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy?
    Oguz EG; Gursoy GK; Yayar O; Yildirim T; Cimen T; Bulut C; Eser B; Canbakan B; Yeter E; Ayli MD
    Ren Fail; 2016 Sep; 38(8):1180-6. PubMed ID: 27416751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: a multicenter prospective study in 23 patients. Sardinian Collaborative Study Group of On-Line Hemofiltration.
    Altieri P; Sorba GB; Bolasco PG; Bostrom M; Asproni E; Ferrara R; Bolasco F; Cossu M; Cadinu F; Cabiddu GF; Casu D; Ganadu M; Passaghe M; Pinna M
    Blood Purif; 1997; 15(3):169-81. PubMed ID: 9262843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients.
    Io H; Matsumoto M; Okumura K; Sato M; Masuda A; Furukawa M; Nohara N; Tanimoto M; Kodama F; Hagiwara S; Gohda T; Shimizu Y; Tomino Y
    Semin Dial; 2011; 24(3):349-54. PubMed ID: 20723158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.